November 18, 2024
Keio University School of Medicine
Hokkaido University
Graduate School of Medical and Dental Sciences, Kagoshima University
Kawasaki Medical School
Hokuto Hospital, Hokuto Social Medical Corporation
Kumagaya General Hospital, Social Medical Corporation
Nagoya University
Craif Inc.
A research group including Professor Hiroshi Nishihara and Project Assistant Professor Yasutaka Kato from the Center for Cancer Genome Medicine, Keio University School of Medicine; Shogo Baba, a researcher (lead author) from the Institute of Oncology and Next-Generation Medicine, Hokuto Hospital; Yuki Ichikawa, CTO of Craif Inc. (Guest Associate Professor, Institute of Innovation for Future Society, Nagoya University); and Yoriko Ando, Project Lecturer at the Institute of Innovation for Future Society, Nagoya University (at the time of the research), has revealed that by analyzing microRNAs in urine using AI (artificial intelligence), early-stage pancreatic cancer can be detected with higher accuracy than conventional blood tests.
The results of this research were published ineClinicalMedicine, a sister journal of The Lancet, on November 12, 2024 (UK time).
For the full press release, please see below.